Previous Article | Next Article ![]()
Journal of Virology, May 1999, p. 4508-4512, Vol. 73, No. 5
Division of Viral Pathogenesis, Department of
Medicine, Beth Israel Deaconess Medical Center, Harvard Medical
School, Boston, Massachusetts 02215
Received 9 November 1998/Accepted 14 February 1999
Evaluation of human immunodeficiency virus type 1-specific mucosal
cytotoxic T lymphocytes can be hampered by limited cell yields from
mucosal sites. We sought to characterize virus-specific CD8+ T lymphocytes with cytotoxic activity in the male
genital tracts of SIVmac-infected rhesus monkeys by using a peptide
epitope-specific functional T-cell assay and a tetrameric major
histocompatibility complex class I-peptide complex. This tetrameric
complex was constructed with the rhesus monkey HLA-A homolog molecule
Mamu-A*01 and a dominant-epitope 9-amino-acid fragment of SIVmac Gag
(p11C, C-M). The proportion of tetramer-positive CD8+ T
cells in semen of SIVmac-infected monkeys ranged from 5.9 to 22.0%. By
the use of a standard 51Cr release assay, these cells were
found to have peptide epitope-specific cytolytic activity after in
vitro expansion. Four-color flow-cytometric analysis of these seminal
tetramer-positive CD8+ T cells demonstrated that they
express memory-associated (CD62L The majority of new human
immunodeficiency virus type 1 (HIV-1) infections are acquired through
sexual activity (15). Cell-free and cell-associated virus
particles are shed in semen (11, 17) and cervicovaginal
secretions (13, 41). Animal studies suggest that this virus
crosses intact genital mucosae in sexually exposed individuals and
infects antigen-presenting cells, such as dendritic cells and
macrophages, in the mucosa of the rectum, the penile foreskin, and the
distal urethra of the male and in the cervix and vagina of the female
(24, 25, 36). Local nonspecific immune mechanisms, such as
proteases, defensins, cytokines, low pH, and
H2O2-producing bacteria (3, 4),
likely influence the efficiency of sexual transmission. Virus-specific
immune defenses in the genital tract have also been documented.
Anti-HIV-1 antibodies have been detected in genital secretions from men
and women (5, 6), and virus-specific cytotoxic T lymphocytes
(CTL) have been demonstrated in cervical specimens (28) and
semen (32).
Accumulating evidence has implicated CTL in containing the systemic
spread of HIV-1 in infected individuals (21). The emergence of HIV-1-specific CTL has been correlated temporally with the damping
of viral replication during primary infection (7). In
addition, a stable clinical status in HIV-1-infected individuals has
been associated with high, persistent levels of circulating CTL
(34). The presence of HIV-1-specific CTL in the reproductive tract suggests that these cells might play a role in limiting sexual
transmission (28, 32).
An animal model that closely parallels the pathogenesis of AIDS is
critical to the elucidation of mucosal events in AIDS
immunopathogenesis and the development of vaccine strategies that
enhance mucosal immune responses against venereally transmitted HIV-1.
Simian immunodeficiency virus (SIV)- and chimeric simian/human
immunodeficiency virus-infected macaques develop an AIDS-like illness
characterized by CD4+-T-lymphocyte loss and the
development of opportunistic infections and tumors (22, 23).
The evaluation of AIDS virus-specific CTL responses in these models has
been facilitated by the definition of CTL epitopes and their
restricting major histocompatibility complex (MHC) class I alleles in
rhesus monkeys (2, 27). However, characterization of mucosal
CTL has proven to be difficult because of the limited cell yields from
sampled mucosal sites. Our laboratory (18) has recently
shown that SIVmac-specific CTL can be detected in relatively small
samples of rhesus monkey cells by utilizing a tetrameric MHC class
I-peptide complex constructed with Mamu-A*01 and the dominant CTL
epitope 9-amino-acid fragment of SIVmac Gag, which we refer to as p11C,
C-M (amino acids 181 to 189). With this technology, we have
characterized virus-specific CTL in the blood and lymph nodes of rhesus
monkeys during primary and chronic SIVmac infection (19, 20)
and in naive monkeys immunized with a recombinant modified vaccinia
virus Ankara-SIV gag-pol construct (35). In the
studies described in this report, we sought to characterize
SIVmac-specific CD8+ T lymphocytes with cytotoxic activity
in male genital fluid by using the tetrameric Mamu-A*01-p11C,
C-M complex.
We first screened multiple semen specimens from five uninfected control
and four SIVmac-infected adult (7- to 10-year-old) rhesus monkeys
(Macaca mulatta) for the presence of lymphocytes by flow
cytometry and microscopy. Animals were maintained in accordance with
the guidelines of the Committee on Animals of the Harvard Medical
School and the Guide for the Care and Use of Laboratory Animals (29). All nine monkeys shared the MHC class I
allele Mamu-A*01, as determined by a PCR-based technique described
elsewhere (16, 18). Infected monkeys received 20 animal
infectious doses of uncloned SIVmac strain 251 by intravenous
inoculation at least 1 year prior to the initiation of these
experiments. All uninfected monkeys and three infected monkeys were
clinically asymptomatic at the time of this study. Infected monkey 575 exhibited chronic wasting and diarrhea consistent with AIDS.
Ejaculates were obtained by electrostimulation of anesthetized monkeys
via a rectal probe method (39). Reproductive performance in
rhesus monkeys can be influenced by environmental factors, such as
season and housing (12, 38). Furthermore, unlike the semen
of most mammalian species, the semen of rhesus monkeys often contains a
small fluid fraction in association with a firm coagulum that resists
liquefaction (14). For these reasons, monkeys were chosen
for this study on the basis of the production of adequate quantities of
seminal fluid during electrostimulation. Seminal cells were washed with
RPMI 1640 supplemented with penicillin (100 U/ml)-streptomycin (100 µg/ml) and 2% fetal bovine serum. Flow-cytometric analyses were
conducted with a Coulter EPICS Elite ESP flow cytometer (Beckman
Coulter, Inc.). Data analysis was performed with EPICS Elite software,
version 4.02 (Beckman Coulter, Inc.). Data presentation was performed
with WINMDI software, version 2.7 (Joseph Trotter, La Jolla, Calif.)
and Power Point software, version 4.0c (Microsoft Corp.).
Mononuclear-cell numbers in freshly collected, unfractionated
ejaculates were enumerated by using a hemacytometer and ranged from 0 to 6 × 105 per ejaculate for the uninfected controls
and from 0 to 9.6 × 106 per ejaculate for the
SIVmac-infected monkeys. On flow-cytometric analysis of multiple
specimens, a distinct cell population with forward- and side-scattering
properties consistent with mononuclear leukocytes was evident in the
semen from only one of the five uninfected control monkeys (data not
shown). The presence of lymphocytes and macrophages was confirmed by
microscopic examination of cytologic preparations of semen. In contrast
to what was observed in the uninfected animals, ejaculates from all
four of the SIVmac-infected monkeys contained lymphocytes and
macrophages during at least one collection period. Semen from one of
the infected monkeys (no. 575) contained an additional cell population
exhibiting the high forward- and side-scattering characteristics of
granulocytic cells; microscopic examination confirmed the presence of
neutrophils, in addition to lymphocytes and macrophages, in this
specimen (data not shown).
We next analyzed those ejaculates with sufficient numbers of
lymphocytes, as well as whole blood anticoagulated with EDTA, for the
presence of T-cell subpopulations by flow cytometry. Mononuclear-cell populations were gated on the basis of forward and side light scattering properties and evaluated for binding of the allophycocyanin (APC)-coupled monoclonal antibody (MAb) FN18, which recognizes rhesus
monkey CD3 (a gift from D. M. Neville, Jr., National Institutes of
Health, Bethesda, Md.), and for the expression of CD4 by using anti-CD4
(OKT4; Ortho Diagnostics Systems, Inc.). Specimens were incubated with
antibodies for 15 min before being washed with phosphate-buffered
saline-2% fetal bovine serum and then fixed with formaldehyde. The
percentages of CD4+ T cells in semen were lower than those
in whole blood for specimens from all monkeys examined, including the
uninfected control monkey with leukocytic semen (61.0 and 38.5% for
blood and semen, respectively) and three of the SIVmac-infected
monkeys, 579 (38.4 and 6.4%), 575 (60.0 and 6.4%), and 403 (32.0 and
25.0%). These findings are in accordance with observations in humans
that have shown low concentrations of CD4+ T cells relative
to the concentrations of CD8+ T cells in semen from
healthy, fertile individuals (40) and in HIV-seropositive
men (33).
To determine whether T-cell populations in semen from SIVmac-infected
monkeys contain a virus-specific CD8+ subset,
unfractionated seminal cells from SIVmac-infected
Mamu-A*01+ rhesus monkeys were analyzed for the presence of
tetrameric Mamu-A*01-p11C, C-M complex-binding CD8+ T
cells (Fig. 1). Previous work has shown
that this tetramer complex primarily binds CD3+
CD8
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Detection of Simian Immunodeficiency Virus
Gag-Specific CD8+ T Lymphocytes in Semen of Chronically
Infected Rhesus Monkeys by Cell Staining with a Tetrameric Major
Histocompatibility Complex Class I-Peptide Complex
and
![]()
ABSTRACT
Top
Abstract
Text
References
CD45RA
)
and activation-associated (CD11a+ Fas+
HLA-DR+) molecules. The present experiments illustrate the
power of tetramer technology for evaluating antigen-specific
CD8+ T lymphocytes in a mucosal tissue compartment.
![]()
TEXT
Top
Abstract
Text
References
/
+ cells (18). Therefore,
Mamu-A*01-p11C, C-M complex-binding cells were evaluated in gated
CD3+ CD8
/
+ cell populations. Tricolor
flow-cytometric analyses of freshly collected, unfractionated seminal
cells (containing 1 × 105 to 6 × 105 spermatozoa) and 100 µl of fresh whole blood were
performed with the soluble phycoerythrin (PE)-coupled tetrameric
Mamu-A*01-p11C, C-M complex as described by Seth et al.
(35). The tetramer was used in conjunction with the MAbs
anti-CD3 (FN18)-APC and anti-CD8
/
(2ST8-5H7)-PE-Texas red
(ECD; Beckman Coulter, Inc.). Specimens were incubated with the
tetramer on ice for 20 min; then antibodies were added. After a 15-min
incubation on ice, the specimens were washed and then fixed in
formaldehyde. Tetramer-binding T cells were undetectable in the
peripheral blood and semen from the uninfected control monkey with
leukocytic semen (Fig. 1). The percentages of tetramer-positive
CD8+ T cells in blood and semen from infected monkeys
ranged from 0.4 to 16% and from 5.9 to 22.0%, respectively. These
values are in the same ranges as those observed in peripheral blood and
lymph nodes of chronically infected monkeys (20).
Interestingly, the percentage of tetramer-positive CD8+ T
cells was higher in semen than in blood for three of the evaluated monkeys (Fig. 1).

View larger version (17K):
[in a new window]
FIG. 1.
Percentages of CD3+ CD8
/
+
cells binding tetrameric Mamu-A*01-p11C, C-M complex in peripheral
blood leukocytes (PBL) and freshly collected semen of an uninfected
Mamu-A*01+ control rhesus monkey with leukocytic semen
(SIV
) and SIVmac-infected, Mamu-A*01+ monkeys (no. 579, 138, 403, and 575) as determined by tricolor flow cytometry.
The low mononuclear-cell yields from these ejaculates precluded the
analysis of cytotoxic activity in freshly collected specimens. Therefore, we assessed antigen- or mitogen-stimulated seminal lymphocytes in three infected monkeys for their ability to recognize and lyse autologous target cells expressing SIVmac gene products. Seminal lymphocytes were obtained by density gradient centrifugation (Ficoll-Hypaque) and expanded for 12 days in
interleukin-2-containing (20 U/ml) medium, after stimulation with
either p11C, C-M-pulsed, irradiated, autologous peripheral blood
mononuclear cells (monkeys 579 and 138) or concanavalin A (5 µg/ml;
Sigma Chemical Co.) (monkey 403) as described elsewhere
(18). Lymphocytes were then assessed as effector cells in a
standard 51Cr release assay by using U-bottomed microtiter
plates containing 104 target cells with various
concentrations of effector cells. Autologous B-lymphoblastoid cell
lines were used as target cells and were incubated with 1 µg of p11C,
C-M (CTPYDINQM)/ml or 1 µg of the negative-control peptide p11B
(ALSEGCTPYDIN)/ml for 90 min during 51Cr labeling. Plates
were incubated in a humidified incubator at 37°C for 4 h.
Specific release was calculated as follows: [(experimental release
spontaneous release)/(maximum release
spontaneous release)] × 100. Spontaneous release was <20% of
the maximal release with detergent (2% Triton X-100) in all assays.
Lysis was assessed at six effector/target ratios.
Total seminal mononuclear-cell numbers increased approximately two to
fivefold upon stimulation in vitro. As shown in Fig. 2 (top), flow-cytometric analysis
demonstrated the presence of tetrameric Mamu-A*01-p11C, C-M
complex-binding CD8
/
+ T cells after cultivation. Gag
epitope-specific cytolytic activity was confirmed in all specimens
after in vitro expansion, as determined by a functional assay (Fig. 2,
bottom). Compared with that in freshly collected seminal cells (Fig.
1), the proportion of tetramer-positive cells doubled in cultured cells
from monkey 579, decreased in cultured cells from monkey 138, and
remained unchanged in cultured cells from monkey 403 (Fig. 2). In a
study of semen from HIV-1-infected humans, the cloning efficiencies of
seminal mononuclear cells were found to be lower than those observed in
blood from the same individual (32). In vitro growth
characteristics of antigen-specific lymphocyte populations in
ejaculates may be influenced, in part, by inhibitory factors in semen
(1, 37) or the absence of sufficient concentrations of
functional antigen-presenting cells. Alternatively, seminal T
lymphocytes may represent end-stage cell populations with a limited
capacity to proliferate.
|
Previous work has shown that epitope-specific CD8+ T cells
in peripheral blood and lymph nodes of SIVmac-infected rhesus macaques express cell surface molecules associated with memory and activation (18, 20). To determine whether tetramer-positive
CD8+ T cells in semen have a similar phenotype,
CD3+ CD8
/
+ tetramer-binding cells from
the ejaculate of an SIVmac-infected, Mamu-A*01+ rhesus
monkey (no. 579) were analyzed by four-color flow cytometry. Analysis
was performed on gated CD3+ CD8
/
+ T cells
in freshly collected, unfractionated seminal cell specimens by using
biotinylated tetrameric Mamu-A*01-p11C, C-M complex coupled to
Alexa 488-labeled NeutrAvidin (Molecular Probes), anti-CD8
-ECD, anti-rhesus monkey CD3-APC, and either anti-CD11a (25.3.1)-PE, anti-CD45RA (2H4)-PE, anti-HLA-DR (MHC class II; 13)-PE (Beckman Coulter, Inc.), anti-CD62L (Leu8)-PE (Becton Dickinson), or anti-CD95 (Fas; DX2)-PE (Caltag).
Similar to circulating and lymph node CTL (18, 20), seminal
tetramer-positive CD8+ T cells expressed the
activation-associated molecules CD11a, CD95, and MCH class II (Fig.
3). Most cells failed to express CD62L
and CD45RA, molecules associated with a naive phenotype (Fig. 3). (No
anti-CD45RO MAb is currently available for staining rhesus monkey
lymphocytes.) A similar array of cell surface molecules was also
expressed on tetramer-negative CD3+ CD8
/
+
T cells from this monkey (Fig. 3). Although the concentration of
lymphocytes available from the uninfected control monkey with leukocytic semen was insufficient for analysis of all of these markers,
approximately 75% of the CD3+ cells in ejaculates from
this animal expressed MHC class II (data not shown). A predominantly
memory-associated phenotype (CD45RO+) has been observed in
CD4+ cell populations in semen from both HIV-seronegative
and -seropositive men (9). Thus, T lymphocytes that are shed
or migrate into the seminal compartment most likely represent
activated, memory populations that can include virus-specific cells.
|
The source of antigen-specific CD8+ T cells in semen is uncertain. Like humans (10, 31), macaques have T-lymphocyte populations in the mucosa and submucosa throughout the male reproductive tract, with the exception of the germ cell compartment (26). The Gag-specific CD8+ T lymphocytes detected in ejaculates from these monkeys were phenotypically similar to CTL previously examined in peripheral blood and lymph nodes (18, 20). However, the discordance between the percentages of tetramer-positive CD8+ T cells in semen and blood in the same monkeys suggests that genital tract CD8+-T-cell populations may not necessarily be influenced by the same factors that regulate systemic cell-mediated immune responses. The suggestion that HIV-1 replication is to some extent compartmentalized in the reproductive tract is supported by data demonstrating differences in virus loads and viral genotypes in genital secretions and blood (8, 30, 42). Thus, seminal CTL activity may reflect regional differences in virus replication, as well as unique environmental factors such as immunosuppressive constituents, prostaglandins, hormones, endogenous microorganisms, or local inflammation.
These results provide evidence that cytolytically active, virus-specific lymphocytes are a component of the regional immune response in the male reproductive tract during chronic SIVmac infection. Obtaining sufficient numbers of viable lymphocytes from genital secretions for functional characterization can be problematic. Therefore, recent studies of HIV-1-specific CTL in the reproductive tract have relied on expanding cells through cloning (28, 32). The present experiments illustrate the power and efficiency of the tetramer technology for directly evaluating freshly collected, antigen-specific CD8+ lymphocytes in vivo, particularly in specimens with limited cell yields.
| |
ACKNOWLEDGMENTS |
|---|
We thank Mike Casto, Marc Belanger, and Prebhat Sehgal at the New England Regional Primate Research Center for assistance in collecting animal specimens.
This work was supported by Public Health Service grant K01RR00109 from the National Center for Research Resources and National Institutes of Health grants AI20729 and AI28147.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Division of Infectious Diseases, Department of Medicine, 547 Burnett-Womack Building, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7030. Phone: (919) 513-2819. Fax: (919) 966-6714. E-mail: holly_jordan{at}med.unc.edu.
Present address: Beckman Coulter, Inc., Miami, FL 33196.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Alexander, N. J., and D. J. Anderson. 1987. Immunology of semen. Fertil. Steril. 47:192-205[Medline]. |
| 2. |
Allen, T. M.,
J. Sidney,
M. F. del Guercio,
R. L. Glickman,
G. L. Lensmeyer,
D. A. Wiebe,
R. DeMars,
C. D. Pauza,
R. P. Johnson,
A. Sette, and D. I. Watkins.
1998.
Characterization of the peptide binding motif of a rhesus MCH class I molecule (Mamu-A*01) that binds an immunodominant CTL epitope from simian immunodeficiency virus.
J. Immunol.
160:6062-6071 |
| 3. | Anderson, D. J. 1996. The importance of mucosal immunology to problems in human reproduction. J. Reprod. Immunol. 31:3-19[Medline]. |
| 4. | Anderson, D. J., J. A. Politch, L. D. Tucker, R. Fichorova, F. Haimovici, R. E. Tuomala, and K. H. Mayer. 1998. Quantitation of mediators of inflammation and immunity in genital tract secretions and their relevance to HIV type 1 transmission. AIDS Res. Hum. Retroviruses 14:S43-S49. |
| 5. | Archibald, D. W., D. J. Witt, D. E. Craen, M. W. Vogt, M. S. Hirsch, and M. Essex. 1987. Antibodies to human immunodeficiency virus in cervical secretions from women at risk for AIDS. J. Infect. Dis. 156:240-241[Medline]. |
| 6. | Belec, L., A. J. Georges, G. Steenman, and P. M. Martin. 1989. Antibodies to human immunodeficiency virus in the semen of heterosexual men. J. Infect. Dis. 159:324-327[Medline]. |
| 7. |
Borrow, P.,
H. Lewicki,
B. H. Hahn,
G. M. Shaw, and M. B. A. Oldstone.
1994.
Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection.
J. Virol.
68:6103-6110 |
| 8. | Coombs, R. W., C. E. Speck, J. P. Hughes, W. Lee, R. Sampoleo, S. O. Ross, J. Dragavan, G. Peterson, T. M. Hooton, A. C. Collier, L. Corey, L. Koutsky, and J. N. Krieger. 1998. Association between culturable human immunodeficiency virus type 1 (HIV-1) in semen and HIV-1 RNA levels in semen and blood: evidence for compartmentalization of HIV-1 between semen and blood. J. Infect. Dis. 177:320-330[Medline]. |
| 9. | Denny, T. N., J. H. Skurnick, A. Garcia, G. Perez, M. R. Passannante, J. Colon, A. Sheffet, S. H. Weiss, and D. Louria. 1996. Lymphocyte immunoregulatory cells present in semen from human immunodeficiency virus (HIV)-infected individuals: a report from the HIV heterosexual transmission study. Cytometry 26:47-51[Medline]. |
| 10. | El-Demiry, M. 1986. Immunohistochemical identification of lymphocyte subsets and macrophages in normal human urothelium using monoclonal antibodies. Br. J. Urol. 58:436-442[Medline]. |
| 11. | Hamed, K. A., M. A. Winters, M. Holodniy, D. A. Katzenstein, and T. C. Merigan. 1993. Detection of human immunodeficiency virus type 1 in semen: effects of disease stage and nucleoside therapy. J. Infect. Dis. 167:798-802[Medline]. |
| 12. | Harrison, R. M., R. Waggoner, and M. R. Clarke. 1989. Determining sperm quality in rhesus monkeys: timing is all. Lab. Anim. 18:30-31. |
| 13. | Henin, Y., L. Mandelbrot, R. Henrion, R. Pradinaud, J. P. Coulaud, and L. Montagnier. 1993. Virus excretion in the cervicovaginal secretions of pregnant and nonpregnant HIV-infected women. J. Acquired Immune Defic. Syndr. 6:72-75. |
| 14. |
Hoskins, D. D., and D. L. Patterson.
1967.
Prevention of coagulum formation with recovery of motile spermatozoa from rhesus monkey semen.
J. Reprod. Fertil.
13:337-340 |
| 15. | Joint United Nations Programme on HIV/AIDS. 1996. The HIV/AIDS situation in mid 1996: global and regional highlights. UNAIDS fact sheet, 1 July 1996. United Nations, New York, N.Y. |
| 16. | Knapp, L. A., E. Lehmann, M. S. Piekarczyk, J. A. Urvater, and D. I. Watkins. 1997. A high frequency of Mamu-A*01 in the rhesus macaque detected by polymerase chain reaction with sequence-specific primers and direct sequencing. Tissue Antigens 50:657-661[Medline]. |
| 17. | Krieger, J. N., R. W. Coombs, A. C. Collier, D. D. Ho, S. O. Ross, J. E. Zeh, and L. Corey. 1995. Intermittent shedding of human immunodeficiency virus in semen: implications for sexual transmission. J. Urol. 154:1035-1040[Medline]. |
| 18. | Kuroda, M. J., J. E. Schmitz, D. H. Barouch, A. Craiu, T. M. Allen, A. Sette, D. I. Watkins, M. A. Forman, and N. L. Letvin. 1998. Analysis of Gag-specific cytotoxic T lymphocytes in simian immunodeficiency virus-infected rhesus monkeys by cell staining with a tetrameric major histocompatibility complex class I-peptide complex. J. Exp. Med. 9:1373-1381. |
| 19. | Kuroda, M. J., J. E. Schmitz, W. A. Charini, C. E. Nickerson, M. A. Lifton, C. I. Lord, M. A. Forman, and N. L. Letvin. Emergence of cytotoxic T lymphocytes coincides with clearance of virus during primary SIVmac infection in rhesus monkeys. J. Immunol., in press. |
| 20. |
Kuroda, M. J.,
J. E. Schmitz,
W. A. Charini,
C. E. Nickerson,
C. I. Lord,
M. A. Forman, and N. L. Letvin.
1999.
Comparative analysis of cytotoxic T lymphocytes in lymph nodes and peripheral blood of simian immunodeficiency virus-infected rhesus monkeys.
J. Virol.
73:1573-1579 |
| 21. |
Letvin, N. L.
1998.
Progress in the development of an HIV-1 vaccine.
Science
280:1875-1880 |
| 22. |
Letvin, N. L.,
M. D. Daniel,
P. K. Sehgal,
R. C. Desrosiers,
R. D. Hunt,
L. M. Waldron,
J. J. MacKey,
D. K. Schmidt,
L. V. Chalifoux, and N. W. King.
1985.
Induction of AIDS-like disease in macaque monkeys with T-cell tropic retrovirus STLV-III.
Science
230:71-73 |
| 23. | Letvin, N. L., and N. W. King. 1990. Immunologic and pathologic manifestations of the infection of rhesus monkeys with simian immunodeficiency virus of macaques. J. Acquired Immune Defic. Syndr. 3:1023-1040. |
| 24. | Miller, C. J. 1994. Mucosal transmission of simian immunodeficiency virus. Curr. Top. Microbiol. Immunol. 188:107-122[Medline]. |
| 25. |
Miller, C. J.,
N. J. Alexander,
S. Sutjipto,
A. A. Lackner,
A. Gettie,
A. G. Hendrickx,
L. J. Lowenstine,
M. Jennings, and P. A. Marx.
1989.
Genital mucosal transmission of simian immunodeficiency virus: animal model for heterosexual transmission of human immunodeficiency virus.
J. Virol.
63:4277-4284 |
| 26. | Miller, C. J., P. Vogel, N. J. Alexander, S. Dandekar, A. G. Hendrickx, and P. A. Marx. 1994. Pathology and localization of simian immunodeficiency virus in the reproductive tract of chronically infected male rhesus macaques. Lab. Investig. 70:255-262[Medline]. |
| 27. | Miller, M. D., H. Yamamoto, A. L. Hughes, D. I. Watkins, and N. L. Letvin. 1991. Definition of an epitope and MHC class I molecule recognized by Gag-specific cytotoxic T lymphocytes in SIVmac-infected rhesus monkeys. J. Immunol. 147:320-329[Abstract]. |
| 28. |
Musey, L.,
Y. Hu,
L. Eckert,
M. Christensen,
T. Karchmer, and M. J. McElrath.
1997.
HIV-1 induces cytotoxic T lymphocytes in the cervix of infected women.
J. Exp. Med.
185:293-303 |
| 29. | National Academy of Sciences. 1996. Guide for the care and use of laboratory animals. National Academy Press, Washington, D.C. |
| 30. | Poss, M., H. L. Martin, J. K. Kreiss, L. Granville, B. Chohan, P. Nyange, K. Mandaliya, and J. Overbaugh. 1995. Diversity in virus populations from genital secretions and peripheral blood from women recently infected with human immunodeficiency virus type 1. J. Virol. 69:8118-8122[Abstract]. |
| 31. | Pudney, J., and D. Anderson. 1991. Orchitis and human immunodeficiency type 1 infected cells in reproductive tissues from men with the acquired immunodeficiency syndrome. Am. J. Pathol. 139:149-160[Abstract]. |
| 32. |
Quayle, A. J.,
W. M. P. Coston,
A. K. Trocha,
S. A. Kalams,
K. H. Mayer, and D. J. Anderson.
1998.
Detection of HIV-1-specific CTLs in the semen of HIV-infected individuals.
J. Immunol.
161:4406-4410 |
| 33. | Quayle, A. J., C. Xu, K. H. Mayer, and D. J. Anderson. 1997. T lymphocytes and macrophages, but not motile spermatozoa, are a significant source of human immunodeficiency virus in semen. J. Infect. Dis. 176:960-968[Medline]. |
| 34. | Rinaldo, C., X.-L. Huang, Z. Fan, M. Ding, L. Beltz, A. Logar, D. Panicali, G. Mazzara, J. Liebmann, M. Cottrill, and P. Gupta. 1995. High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors. J. Virol. 69:5838-5842[Abstract]. |
| 35. |
Seth, A.,
I. Ourmanov,
M. J. Kuroda,
J. E. Schmitz,
M. W. Carroll,
L. S. Wyatt,
B. Moss,
M. A. Forman,
V. M. Hirsch, and N. L. Letvin.
1998.
Recombinant modified vaccinia virus Ankara-simian immunodeficiency virus gag pol elicits cytotoxic T lymphocytes in rhesus monkeys detected by a major histocompatibility complex class I/peptide tetramer.
Proc. Natl. Acad. Sci. USA
95:10112-10116 |
| 36. |
Spira, A. I.,
P. A. Marx,
B. K. Patterson,
J. Mahoney,
R. A. Koup,
S. M. Wolinsky, and D. D. Ho.
1996.
Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques.
J. Exp. Med.
183:215-225 |
| 37. | Vernazza, P. L., J. J. Eron, and S. A. Fiscus. 1996. Sensitive method for the detection of infectious HIV in semen of seropositive individuals. J. Virol. Methods 56:33-40[Medline]. |
| 38. | Wickings, E. J., and E. Neischlag. 1980. Seasonality in endocrine and exocrine testicular function of the adult rhesus monkey (Macaca mulatta) maintained in a controlled laboratory environment. Int. J. Androl. 3:87-104[Medline]. |
| 39. | Wildt, D. E. 1986. Spermatozoa: collection, evaluation, metabolism, freezing, and artificial insemination, p. 171-193. In W. R. Dukelow, and J. Erwin (ed.), Comparative primate biology, vol. 3. Alan R. Liss, Inc., New York, N.Y. |
| 40. | Witkin, S. S., and M. Goldstein. 1988. Reduced levels of T suppressor/cytotoxic lymphocytes in semen from vasovasectomized men: relationship to sperm autoantibodies. J. Reprod. Immunol. 14:283-290[Medline]. |
| 41. | Wofsy, C. B., L. B. Hauer, B. A. Michaelis, J. B. Cohen, N. S. Padian, L. A. Evans, and J. A. Levy. 1986. Isolation of AIDS-associated retrovirus from genital secretions of women with antibodies to the virus. Lancet i:527-529. |
| 42. | Zhu, T., N. Wang, A. Carr, D. S. Nam, R. Moor-Jankowski, D. A. Cooper, and D. D. Ho. 1996. Genetic characterization of human immunodeficiency virus type 1 in blood and genital secretions: evidence for viral compartmentalization and selection during sexual transmission. J. Virol. 70:3098-3107[Abstract]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»